190 related articles for article (PubMed ID: 8996763)
21. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.
Roche B; Roque-Afonso AM; Nevens F; Samuel D
Transplantation; 2015 Jul; 99(7):1321-34. PubMed ID: 26038873
[TBL] [Abstract][Full Text] [Related]
22. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation.
Féray C; Gigou M; Samuel D; Ducot B; Maisonneuve P; Reynès M; Bismuth A; Bismuth H
Ann Intern Med; 1998 May; 128(10):810-6. PubMed ID: 9599192
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
Protzer-Knolle U; Naumann U; Bartenschlager R; Berg T; Hopf U; Meyer zum Büschenfelde KH; Neuhaus P; Gerken G
Hepatology; 1998 Jan; 27(1):254-63. PubMed ID: 9425945
[TBL] [Abstract][Full Text] [Related]
24. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
25. [Prolonged administration of hepatitis B hyperimmune gamma globulin in patients with liver transplantation in liver diseases caused by hepatitis B virus].
Restrepo JC; Rimola A; Mas A; Navasa M; Salmerón JM; Cirera I; García-Valdecasas JC; Grande L; Visa J; Rodés J
Gastroenterol Hepatol; 1996 Dec; 19(10):491-6. PubMed ID: 9044746
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.
Müller R; Gubernatis G; Farle M; Niehoff G; Klein H; Wittekind C; Tusch G; Lautz HU; Böker K; Stangel W
J Hepatol; 1991 Jul; 13(1):90-6. PubMed ID: 1918881
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
Yang Y; Zhang Q; Cai CJ; Lu MQ; Li X; Jiang N; Jiang H; Xu C; Li H; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Zhang YC; Chen GH
Chin Med J (Engl); 2007 Aug; 120(16):1400-3. PubMed ID: 17825167
[TBL] [Abstract][Full Text] [Related]
28. Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
Iacob S; Hrehoret D; Matei E; Dorobantu B; Gangone E; Gheorghe L; Popescu I
J Gastrointestin Liver Dis; 2008 Dec; 17(4):383-8. PubMed ID: 19104697
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for HBV-related disease under immunosuppression with tacrolimus: an experience with 78 consecutive cases.
Bronsther O; Ersoz S; Tugcu M; Eghtesad B; Gurakar A; Van Thiel DH
J Okla State Med Assoc; 1995 Mar; 88(3):103-8. PubMed ID: 7539077
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
Carman WF; Trautwein C; van Deursen FJ; Colman K; Dornan E; McIntyre G; Waters J; Kliem V; Müller R; Thomas HC; Manns MP
Hepatology; 1996 Sep; 24(3):489-93. PubMed ID: 8781312
[TBL] [Abstract][Full Text] [Related]
32. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
[TBL] [Abstract][Full Text] [Related]
33. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
[TBL] [Abstract][Full Text] [Related]
34. Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.
Stravitz RT; Shiffman ML; Kimmel M; Puri P; Luketic VA; Sterling RK; Sanyal AJ; Cotterell AH; Posner MP; Fisher RA
Liver Int; 2012 Aug; 32(7):1138-45. PubMed ID: 22348467
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
Neff GW; O'brien CB; Nery J; Shire N; Montalbano M; Ruiz P; Nery C; Safdar K; De Medina M; Tzakis AG; Schiff ER; Madariaga J
Liver Transpl; 2004 Nov; 10(11):1372-8. PubMed ID: 15497163
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation in European patients with the hepatitis B surface antigen.
Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
[TBL] [Abstract][Full Text] [Related]
39. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
40. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
